MARKET

CYTO

CYTO

Altamira Therapeutics Ltd
NASDAQ
1.395
+0.005
+0.36%
Closed 17:37 07/17 EDT
OPEN
1.400
PREV CLOSE
1.390
HIGH
1.420
LOW
1.390
VOLUME
23.17K
TURNOVER
0
52 WEEK HIGH
17.20
52 WEEK LOW
1.050
MARKET CAP
3.73M
P/E (TTM)
-0.9750
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at CYTO last week (0708-0712)?
Weekly Report · 2d ago
Weekly Report: what happened at CYTO last week (0701-0705)?
Weekly Report · 07/08 12:12
Weekly Report: what happened at CYTO last week (0624-0628)?
Weekly Report · 07/01 12:13
Weekly Report: what happened at CYTO last week (0617-0621)?
Weekly Report · 06/24 12:24
Weekly Report: what happened at CYTO last week (0610-0614)?
Weekly Report · 06/17 12:11
Weekly Report: what happened at CYTO last week (0603-0607)?
Weekly Report · 06/10 12:15
Weekly Report: what happened at CYTO last week (0527-0531)?
Weekly Report · 06/03 12:18
ALTAMIRA THERAPEUTICS LTD - MERGED ENTITY WILL BE CALLED ALTAMIRA THERAPEUTICS AG AND CONTINUE TO SERVE AS CORE OPERATING SUBSIDIARY OF COMPANY
Reuters · 05/28 14:31
More
About CYTO
Altamira Therapeutics Ltd. is a Bermuda-based company engaged in developing ribonucleic acid (RNA)-based therapeutics for extrahepatic targets (OligoPhore/SemaPhore delivery platforms). The Company has two flagship short interfering (siRNA) programs in preclinical development beyond in vivo proof of concept: AM-401 for KRAS driven cancer and AM-411 for rheumatoid arthritis. The delivery platform is also suited for messenger RNA (mRNA) and other types of RNA therapeutics and is focused to be leveraged via out-licensing to pharma or biotech companies. The therapeutic objective for AM-401 is to slow down KRAS driven tumor cell growth and proliferation or to stop it altogether by delivering siRNA specifically inside tumor cells for gene knock down. AM-411 is a polyplex nanoparticle delivering siRNA to inflamed tissues to target the NF-kB signaling pathway, a critical regulator of immune and inflammatory responses. Like AM-401, the drug product is based on its OligoPhore technology.

Webull offers Altamira Therapeutics Ltd stock information, including NASDAQ: CYTO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CYTO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CYTO stock methods without spending real money on the virtual paper trading platform.